Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/27/2010 | CN100584199C A method for evoking yili caladium polyploid under culture in vitro |
01/26/2010 | US7652202 Barley cultivar salute |
01/26/2010 | US7652192 Cloning of transgenic unglulates comprising artificial chromosomes |
01/26/2010 | US7652077 Graft prosthesis, materials and methods |
01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
01/26/2010 | US7651856 Mounting device for mounting a retainer means for a biological object and corresponding method for laser micro-dissection |
01/26/2010 | US7651855 Ex vivo activated; provide sufficient amounts of culture expanded isolated CD4+CD25+ suppressor Treg cells; long term suppressor capability; therapeutic prevention, blocking, inhibiting the rejection of transplanted tissue, protecting against graft vs host disease; donor cells allogeneically introduced |
01/26/2010 | US7651854 Administering PC cell-derived growth factor (PCDGF); improves the efficiency of primary hematopoietic cell culture |
01/26/2010 | US7651853 Cultures of GFAP+ nestin+ cells that differentiate to neurons |
01/26/2010 | US7651847 Methods of oligosaccharide profiling for the detection of cancer |
01/26/2010 | US7651684 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
01/26/2010 | CA2349629C Methods for the production of tcr gamma delta t cells |
01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
01/26/2010 | CA2309907C Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
01/26/2010 | CA2294703C Plasmids for plant transformation and method for using the same |
01/26/2010 | CA2230033C Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
01/26/2010 | CA2216630C Cell line and processes for replicating rabies viruses and detecting them quantitatively |
01/26/2010 | CA2144279C Medium-penetrating cell culture carrier and a culturing method and a device using this carrier |
01/21/2010 | WO2010009147A1 Recognition sequences for i-crei-derived meganucleases and uses thereof |
01/21/2010 | WO2010009015A2 Production of pluripotent cells through inhibition of bright/arid3a function |
01/21/2010 | WO2010008568A1 Tm4sf4 and modulators thereof and methods for their use |
01/21/2010 | WO2010008486A2 Pluripotent cell lines and methods of use thereof |
01/21/2010 | WO2010008075A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
01/21/2010 | WO2010008054A1 Method for production of reprogrammed cell using chromosomally unintegrated virus vector |
01/21/2010 | WO2010008051A1 Anti-human clcp1 antibody and use thereof |
01/21/2010 | WO2010008044A1 Novel protein having endoglucanase activity, dna of the protein, and use of the same |
01/21/2010 | WO2010008010A1 Hcv/gbv-b chimeric virus |
01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
01/21/2010 | WO2010007622A2 Long-acting interferons and derivatives thereof and methods thereof |
01/21/2010 | WO2010007549A1 Process for providing an assembly of cell microcarriers |
01/21/2010 | WO2010007524A2 Materials and methods for cell growth |
01/21/2010 | WO2010007118A1 Method for cell identification and cell sorting |
01/21/2010 | WO2010007031A2 Methods for improving cardiac differentiation of human embryonic stem cells |
01/21/2010 | WO2010006989A1 Scalable process for culturing per.c6 cells and producing products therefrom |
01/21/2010 | WO2010006452A1 New influenza virus immunizing epitope |
01/21/2010 | WO2010006373A1 High fructan cereal plants |
01/21/2010 | WO2009145419A3 Composition comprising vegetable peptone for promoting stem cell proliferation |
01/21/2010 | WO2009143308A3 Protein self-producing artificial cell |
01/21/2010 | WO2009142724A3 Novel gpr101 transgenic mice and methods of use thereof |
01/21/2010 | WO2009137629A3 Methods for producing enucleated erythroid cells derived from pluripotent stem cells |
01/21/2010 | WO2009137135A3 On-orbit procedures for adapting plants and animals to hostile environments |
01/21/2010 | WO2009134418A3 Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby |
01/21/2010 | WO2009132220A3 Isoprene synthase variants for improved microbial production of isoprene |
01/21/2010 | WO2009132129A3 Isoform-specific insulin analogues |
01/21/2010 | WO2009126650A3 Inhibition of angiognesis |
01/21/2010 | WO2009111723A9 Electrowetting microarray printing system and methods for bioactive tissue construct manufacturing |
01/21/2010 | WO2009099555A3 Synthetic surfaces for culturing cells in chemically defined media |
01/21/2010 | WO2009097006A3 Hco32 and hco27 and related examples |
01/21/2010 | WO2006039470A9 Anti- amyloid antibodies, compositions, methods and uses |
01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
01/21/2010 | WO2003057859A9 Genes for altering mitochondrial function and for hybrid seed production |
01/21/2010 | WO2003006609A9 Human cytokine receptor |
01/21/2010 | US20100017919 Rice Gene, GS3, Exerting Primary Control Over Grain Length and Grain Weight |
01/21/2010 | US20100017917 Transgenic plants with tocopherol methyltransferase |
01/21/2010 | US20100017916 Systems for reducing biomass recalcitrance |
01/21/2010 | US20100017915 Manipulation of Plant Polysaccharide Synthases |
01/21/2010 | US20100017914 Insecticidal proteins |
01/21/2010 | US20100017909 Nitrate transport components |
01/21/2010 | US20100017904 Genes and uses for plant improvement |
01/21/2010 | US20100017903 Slow-maturing, determinate peas |
01/21/2010 | US20100017899 Method for the isolation of pluripotent cells from a pre-implantation embryo in a culture medium free from animal serum |
01/21/2010 | US20100017895 Small animal model for hcv replication |
01/21/2010 | US20100017894 Mutants of Human App and Their Use for the Production of Transgenice Animals |
01/21/2010 | US20100017865 Method and system for preventing fraudulent activities |
01/21/2010 | US20100016565 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
01/21/2010 | US20100016556 Method for making humanized antibodies |
01/21/2010 | US20100016553 Internalization |
01/21/2010 | US20100016434 Inhibitors of Egln3 Activity for the Treatment of Neurodegenerative Disorders |
01/21/2010 | US20100016424 Production and use of derivatized homoserine lactones |
01/21/2010 | US20100016415 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their use as Diagnostic Reagents and Vaccines |
01/21/2010 | US20100016414 Targets for human micro rnas in avian influenza virus (h5n1) genome |
01/21/2010 | US20100016411 Method of modulation of expression of epidermal growth factor receptor(egfr) involving mirna |
01/21/2010 | US20100016410 Methods and Compositions Related to Eosinophil Regulation |
01/21/2010 | US20100016408 Modulating the cdc14b-cdh1-plk1 axis and methods for sensitizing target cells to apoptosis |
01/21/2010 | US20100016405 Compositions and Methods for Inhibiting Expression of the MYC Gene |
01/21/2010 | US20100016313 Intestinal alkaline phosphatase modulators and uses thereof |
01/21/2010 | US20100016242 Myosin light chain kinase inhibitors and methods of use |
01/21/2010 | US20100016241 Methods and compositions for inhibiting c-met dimerization and activation |
01/21/2010 | US20100016228 Truncated bard1 protein, and its diagnostic and therapeutic uses |
01/21/2010 | US20100016216 Adiponectin and uses thereof |
01/21/2010 | US20100015713 Components of cell culture media produced from plant cells |
01/21/2010 | US20100015712 Side population cells originated from human amnion and their uses |
01/21/2010 | US20100015711 Differentiation of Pluripotent Stem Cells |
01/21/2010 | US20100015710 Methods and Compositions for Isolating, Maintaining and Serially Expanding Human Mesenchymal Stem Cells |
01/21/2010 | US20100015709 Regulating Stem Cell Differentiation By Controlling 2D and 3D Matrix Elasticity |
01/21/2010 | US20100015707 SHORT INTERFERING RIBONUCLEIC ACID (siRNA) FOR ORAL ADMINISTRATION |
01/21/2010 | US20100015705 Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions |
01/21/2010 | US20100015704 Process for the enrichment of melanocytes by means of modified surfaces |
01/21/2010 | US20100015702 Generation, Characterization and Isolation of Neuroepithelial Stem Cells and Lineage Restricted Intermediate Precursor |
01/21/2010 | US20100015701 Novel fluorescent proteins and methods for using same |
01/21/2010 | US20100015664 Protease, dna encoding the same, and method for manufacturing protease |
01/21/2010 | US20100015654 Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells |
01/21/2010 | US20100015637 Pigf-1 assay and kits and components thereof |
01/21/2010 | US20100015615 Identification and Isolation of Adult Stem Cells and Related Methods of Use |
01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
01/21/2010 | US20100015244 Nano/Macroporous Bioactive Glasses Made by Melt-Quench Methods |